Skip to main content

Dermata Therapeutics (US:DRMA) — Company Overview, News & Financial Data

Dermata Therapeutics logo
DRMADermata Therapeutics
Dermata Therapeutics primary media
Company profile

Dermata Therapeutics

About

Explore United States companies

Dermata Therapeutics (NASDAQ:DRMA) is a dynamic health entity dedicated to developing innovative treatments across a broad spectrum of dermatological conditions. They focus on addressing unmet medical needs for patients struggling with acne, rosacea, and other skin-related ailments. Dermata Therapeutics is determined to push the boundaries of skincare by investing in research and development projects that pave the way for breakthrough treatments. Their objective remains clear: to revolutionize dermatological care and enhance patient well-being through effective, accessible, and novel therapeutic options.

Snapshot

Public USOwnership
2014Year founded
8Employees
San Diego, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
San Diego, US

Products and/or services of Dermata Therapeutics

  • Development of innovative therapies targeting dermatological conditions like acne, rosacea, and psoriasis.
  • Research on cutting-edge biologic treatments for severe skin diseases.
  • Formulation of advanced skincare products leveraging proprietary drug delivery technologies.
  • Collaboration with other biotech firms to co-develop dermatological solutions.
  • Engagement in clinical trials to validate the efficacy and safety of new dermatologic treatments.
  • Provision of comprehensive patient support programs to enhance treatment accessibility and adherence.

Dermata Therapeutics executive team

  • Mr. Gerald T. ProehlFounder, President, CEO & Chairman
  • Mr. David F. HaleCo-Founder & Lead Independent Director
  • Ms. Kyri K. Van Hoose CPA, M.B.A.Senior VP & CFO
  • Dr. Christopher J. Nardo M.P.H., Ph.D.Senior VP & Chief Development Officer
  • Mr. Sean ProehlAssociate General Counsel
  • Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.Senior Vice President of Regulatory Affairs & Quality Assurance